Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Pascual-Guardia (Barcelona, Spain), R. Mas (Barcelona, Spain), R. Faner (Barcelona, Spain), A. Castro-Acosta (Madrid, Spain), G. Peces-Barba (BMadrid, Spain), B. Cosio (Palma, Spain), A. Agustí (Barcelona, Spain), E. Monsó (Sabadell, Spain), J. Gea Guiral (Barcelona, Spain). Protein profile of COPD patients with Pseudomonas in their airway secretions. 2342

Member's Comments

No comment yet.

Related content which might interest you: Airway FABP4 is decreased in COPD patients with airway bacterial infection Source: International Congress 2019 – Airway infection in COPD Year: 2019 Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients Source: Eur Respir J 2008; 32: 740-747 Year: 2008 Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015 Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Increased uptake of haemophilus influenzae by primary airway epithelial cells from COPD patients Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Induced sputum and airway inflammation in asthma and COPD Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006 Bacterial infection in patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002 Lung function and bacterial pathogens in sputum of patients with acute exacerbation of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 408s Year: 2004 Bacterial flora in sputum and relationship with lung function in patients with acute exacerbation of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 Changes in the induced sputum proteome during COPD exacerbations Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 High mortality in COPD patients with isolation of aspergillus spp in bronchial secretions Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Effect of lower airway bacterial colonisation on time to acute exacerbation in patients with COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Pseudomonas aeruginosa drug susceptibility in patients hospitalized with COPD exacerbation and bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001 The airway microbiota and exacerbations of COPD Source: ERJ Open Res, 6 (3) 00168-2020; 10.1183/23120541.00168-2020 Year: 2020 Analysis of airway mucin concentration in patients with pulmonary eosinophilia Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 The airway microbiota is significantly altered in asthma patients with airway hyperresponsiveness to mannitol Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Bacterial airway colonization is not associated with increased procalcitonin in stable COPD Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012 The study of airway microbiome and mycobiome of COPD and AECOPD patients Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Chronic sputum production in COPD is a marker for airway inflammation and colonisation Source: Eur Respir J 2004; 24: Suppl. 48, 306s Year: 2004